FDA Inspection 1338618 — Ultra Seal Corporation

Ultra Seal Corporation — FEI 1317759

The FDA completed an inspection of Ultra Seal Corporation on Sep 3, 2026 in New Paltz, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 3, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New Paltz, NY (United States)

Citations

IDCFRDescription
121921 CFR 211.67(b)(2)Cleaning SOPs/schedules

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.